About Nobel Laboratories
nobellabs.com
Home
Products
Store
Health News
About Us
Affiliates
Contact


Life is not being alive but being well.

Life Expectancy is Increasing
Nobel Laboratories believes in the motto "life is not being alive but being well." Life expectancy is an excellent indicator of a population’s overall health. In the past 100 years, life expectancy jumped 30 years to 74 for men and 80 for women. Deaths from heart disease declined 4%, cancer deaths decreased 2% and stroke deaths fell nearly 5%. But deaths from kidney disease, hypertension, Alzheimer’s disease and skin cancer have increased. Many of these disorders are associated with oxidative stress, or the predominance of free radicals over antioxidant mechanisms. Inadequate dietary intake of antioxidants can result in oxidative stress, which has been implicated in premature aging, heart disease, arthritis, cancer, Alzheimer’s disease, cataracts, glaucoma, diabetic retinopathy and macular degeneration.

Much has been learned in the past 20 years regarding the aging process. By 2005, one in four Americans will be 55 or older, a population that wants an active lifestyle and maintaining good health. We, at Nobel Laboratories are dedicated to finding practical answers to everyday medical problems.

Discovering a Solution to Arthritis Pain
Finding a solution for the symptoms associated with arthritis, we focused on the problem of making new articular cartilage. Studies showed that taking oral glucosamine resulted in new articular cartilage, but the results were not consistent. Further research disclosed the presence of a gas, nitric oxide, produced by the joint capsule in those with osteoarthritis and rheumatoid arthritis, that prevented chondrocytes (cartilage making cells) from converting glucosamine into new cartilage. When nitric oxide production was reduced by blocking an enzyme, nitric oxide synthase, the glucosamine produced new cartilage. The result was the invention of Nu-Joint, a formulation of dietary supplements that makes and repairs new cartilage. This composition has received two patents.

A New Aspirin
During the past century indications for aspirin have exploded, but the tablet design has been stagnant.  With the exception of the enteric coated tablet, to avoid contact with the stomach, the only new advance has been the orally disintegrating tablet, where the tablet melts in the mouth after contact with saliva on the tongue and is absorbed by the lining of the mouth, avoiding first-pass metabolism and irritation to the gastrointestinal tract.  Fasprin® is a low-dose aspirin tablet that enters the bloodstream in five minutes which is important for someone having a heart attack, stroke or migraine headache. 

Send your suggestions or comments

View patent information

Home